Geoffrey M. Curtis is CCO & VP at Horizon Therapeutics Public Ltd Co (HZNP). They have made 6 open-market trades across 1 company since 2018, most recently 2021-04-01.
CIK 0001667903
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HZNP | 52,675 | $6.1M |
Shares reported on the most recent Form 4, priced at the 2021-04-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | SELL | 2021-04-01 | 2021-04-02 | $93.51 | $13.2M | +0.4% | +1.8% | +6.0% |
| HZNP | SELL | 2020-05-26 | 2020-05-27 | $49.85 | $2.2M | +0.3% | +12.8% | +50.9% |
| HZNP | SELL | 2019-08-08 | 2019-08-12 | $26.58 | $1.1M | +5.0% | +1.3% | +13.8% |
| HZNP | SELL | 2019-02-25 | 2019-02-25 | $21.21 | $214K | +24.4% | +25.4% | +18.0% |
| HZNP | SELL | 2019-02-05 | 2019-02-05 | $23.16 | $205K | -0.3% | +11.1% | +18.2% |
| HZNP | SELL | 2018-08-16 | 2018-08-20 | $20.63 | $409K | +0.2% | -8.5% | +7.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.